Comparison of the Surgical Pleth Index and the Nociception Level Index in the Pediatric Population
NCT ID: NCT07084935
Last Updated: 2025-07-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
40 participants
OBSERVATIONAL
2025-07-04
2026-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators hypothesize that the NOL monitor and SPI monitor will both be able to quantify surgical stimuli and tetanic stimuli with monitors response to surgical stimuli \> monitors response to tetanic stimuli. However, the investigators also hypothesize that the NOL index will do this superiorly, as it utilizes a self-learning algorithm and more parameters are incorporated in its algorithm
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Surgical Pleth Index During Spinal and General Anesthesia
NCT00789438
Evaluation Of The Analgesia Nociception Index vs. Surgical Pleth Index Under General And Regional Anaesthesia
NCT02744573
The Use of Surgical Pleth Index in Guiding Anesthesia in Gastroenterological Surgery
NCT04519203
Evaluating the Predictive Value of the Nociception Level Index NOL
NCT03324269
Impact of NOL Index Intraoperative Guided Remifentanil Analgesia
NCT04402242
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
During the operation the response to the standardised stimuli and nociceptive events such as intubation, insertion of supraglottic airway, surgical incision and administration of opioids will be registered by a trained researcher. After surgery, upon discharge to the anaesthesia recovery room, patients will be disconnected from both monitors. Post-operative pain/comfort scores and post-operative analgesia usage will be registered by the researcher at the recovery room. Total duration of the study inclusion period is expected to be 1 year.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients aged 1 to 12 years undergoing surgery with general anesthesia.
Connecting all patients to the nociception level index(NOL) and the surgical pleth index (SPI)
All patients will be connected to the NOL and SPI during surgery after induction of general anesthesia.
All patient will receive a tetanic stimuli (60mA, 100hz) of 5 seconds before start of incision
All patient will receive a tetanic stimuli (60mA, 100hz) of 5 seconds before start of incision.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Connecting all patients to the nociception level index(NOL) and the surgical pleth index (SPI)
All patients will be connected to the NOL and SPI during surgery after induction of general anesthesia.
All patient will receive a tetanic stimuli (60mA, 100hz) of 5 seconds before start of incision
All patient will receive a tetanic stimuli (60mA, 100hz) of 5 seconds before start of incision.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ASA I, ASA II and ASA III
* Aged 1 to 12 years old
* Scheduled to undergo elective surgery with general anaesthesia
Exclusion Criteria
* Patients with chronic analgesia usage.
* Known allergy to the adhesives used in the sensors.
* No free available limb to attach the probes to.
1 Year
12 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Ignacio Malagon
prof. Jose Ignacio Malagon Calle MD, PhD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ignacio Malagon, Professor
Role: PRINCIPAL_INVESTIGATOR
Radboud University Medical Center
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Radboud university medical centre
Nijmegen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2025-18010
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.